Efficient transduction of dendritic cells and induction of a T-cell response by third-generation lentivectors

Human Gene Therapy

Volumn 13, Issue 9, 2002, Pages 1091-1100

  Esslinger, Christoph ^a   Romero, Pedro ^a   Macdonald, H Robson ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD8 ANTIGEN; EPITOPE; GAMMA INTERFERON; LENTIVIRUS VECTOR;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BRAIN DISEASE; CONTROLLED STUDY; DENDRITIC CELL; GENE THERAPY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNITY; IMMUNOTHERAPY; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; GENETIC VECTORS; HIV-1; HUMANS; INTERFERON TYPE II; LENTIVIRUS; MICE; MICE, TRANSGENIC; PHENOTYPE; T-LYMPHOCYTES; TRANSDUCTION, GENETIC;

ADENOVIRIDAE; ANIMALIA; LENTIVIRUS;

EID: 0036288752     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/104303402753812494     Document Type: Article

References (40)

1. Monocyte-derived dendritic cells do not proliferate and are not susceptible to retroviral transduction
2. A comparison of gene transfer methods in human dendritic cells
3. Differential requirement for CD4 help in the development of an antigen-specific CD8+ T cell response depending on the route of immunization
4. Dramatic influence of V beta gene polymorphism on an antigen-specific CD8+ T cell response in vivo
5. Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires
6. Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor
7. H-2-restricted cytolytic T lymphocytes specific for HLA display T cell receptors of limited diversity
8. Antibodies against the two serotypes of vesicular stomatitis virus measured by enzyme-linked immunosorbent assay: Immunodominance of serotype-specific determinants and induction of asymmetrically cross-reactive antibodies
9. Gene therapy with recombinant adenovirus vectors: Evaluation of the host immune response
10. A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas
11. VSV-G pseudotyped lentiviral vector particles produced in human cells are inactivated by human serum
12. High efficiency adenovirus-mediated gene transfer to human dendritic cells
13. Immunological function of HLA-C antigens in HLA-Cw3 transgenic mice
14. A third-generation lentivirus vector with a conditional packaging system
15. Gene transfer by lentiviral vectors is limited by nuclear translocation and rescued by HIV-1 pol sequences
16. Retroviral gene transfer, rapid selection, and maintenance of the immature phenotype in mouse dendritic cells
17. The biochemistry and cell biology of antigen processing and presentation
18. Dendritic cells transduced by multiply deleted HIV-1 vectors exhibit normal phenotypes and functions and elicit an HIV-specific cytotoxic T-lymphocyte response in vitro
19. A simplified system for generating recombinant adenoviruses
20. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor
21. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox
22. Viral vectors for dendritic cell-based immunotherapy
23. Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2-restricted tumor infiltrating lymphocytes
24. Comparative analysis of genetically modified dendritic cells and tumor cells as therapeutic cancer vaccines
25. Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease
26. Oligoclonal expansion of major histocompatibility complex class I- restricted cytolytic T lymphocytes during a primary immune response in vivo: Direct monitoring by flow cytometry and polymerase chain reaction
27. Gene therapy death prompts review of adenovirus vector
28. H2-restricted recognition of cloned HLA class I gene products expressed in mouse cells
29. H-2-restricted cytolytic T cells specific for HLA can recognize a synthetic HLA peptide
30. Pulmonary inflammation induced by incomplete or inactivated adenoviral particles
31. Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway
32. Immunogene therapy for murine melanoma using recombinant adenoviral vectors expressing melanoma-associated antigens
33. Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes
34. Retroviral transduction of human dendritic cells with a tumor-associated antigen gene
35. Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity
36. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases
37. Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues
38. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
39. Recombinant adenovirus is an efficient and non-perturbing genetic vector for human dendritic cells
40. Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery